Skip to main content

Featured

Posted by

Adani Out, China In: Why Is Kenya's New JKIA Deal Sh137 Billion More Expensive?

When the government abruptly pulled the plug on the controversial JKIA deal with India's Adani Group, many Kenyans breathed a sigh of relief. The project had become a lightning rod for public anger. Questions swirled around transparency, value for money, and the wisdom of effectively handing over the country's most important airport to a foreign company for decades. Critics described it as a bad deal. Government officials appeared to agree. The message was simple: Kenya deserved better. Now, barely two years later, reports have emerged that a Chinese firm has secured a contract worth approximately Sh375 billion to upgrade Jomo Kenyatta International Airport. Pause for a moment and let that sink in. The Adani proposal that sparked a national uproar was reportedly valued at around Sh238 billion. The new deal is said to be worth roughly Sh137 billion more. Naturally, a natural question arises:  What exactly changed? The Price Tag Nobody Is Talking About The first thing that jumps ...
Post a Comment
Read more
Labels
Posted by

The Truth Behind Ozempic: Diabetes Drug or Weight-Loss Miracle?

In a society where the pursuit of the 'perfect body' is often glorified, the emergence of Ozempic, a medication primarily used for managing Type 2 diabetes, as a purported weight-loss solution has stirred considerable attention. Marketed as a game-changer by celebrities and social media influencers, Ozempic's journey from a diabetes drug to a trending weight-loss remedy warrants closer examination.

Ozempic's ascent to social media stardom stems from its ability to regulate blood sugar levels and facilitate weight loss among diabetic individuals. Despite being intended for diabetes management, its off-label use for weight loss has garnered significant traction, fueled by celebrity endorsements and viral TikTok testimonials.

Dr Ian Justus, a Nairobi-based physician, sheds light on Ozempic's mechanism of action. The drug, also known as Semaglutide, mimics the function of a naturally occurring hormone in the body, glucagon-like peptide-1 (GLP-1). By increasing GLP-1 levels, Ozempic signals to the brain that one is full and slows down digestion, leading to reduced appetite and delayed stomach emptying.

However, it is crucial to emphasise that Ozempic is a prescription-only medication, underscoring the importance of medical oversight. Dr Justus highlights that the drug is contraindicated for individuals with certain types of thyroid cancers, emphasising the need for thorough medical evaluation before its usage.

The surge in off-label prescriptions for weight loss has resulted in global supply shortages and paved the way for the proliferation of counterfeit drugs, exacerbating health risks for consumers. Online platforms offer Ozempic at exorbitant prices without the requisite prescription, raising concerns about the authenticity and safety of the product.

Moreover, while Ozempic may yield weight loss benefits, it's not devoid of side effects. Nausea, dehydration, fatigue, and malnutrition are common complaints among users, with long-term risks including thyroid cancer posing significant concerns.

In light of these developments, it's imperative for individuals to prioritize informed decision-making and consult healthcare professionals before embarking on Ozempic or any other medication regimen. The allure of rapid weight loss must be balanced against potential health risks, underscoring the importance of evidence-based approaches to wellness.

While Ozempic's popularity as a weight-loss aid continues to soar, a nuanced understanding of its efficacy, safety profile, and regulatory framework is essential. By navigating the hype with caution and discernment, individuals can safeguard their health and well-being in pursuit of their fitness goals.

Labels:

Comments

Post a Comment